Want to join the conversation?
Test-and-measurement equipment maker $A reported higher 4Q15 results, helped by significant YoverY margin improvements and reduction in total costs and expenses. $A said net income rose 509% to $140MM, or $0.42 per share, and revenue fell 1% to $1.04Bil.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.